IPSC-CTL Trademark
Trademark Overview
On Tuesday, February 6, 2024, a trademark application was filed for IPSC-CTL with the United States Patent and Trademark Office. The USPTO has given the IPSC-CTL trademark a serial number of 98393461. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, December 3, 2024. This trademark is owned by Shanghai Xinghua Bio Pharmaceutical Science & Technology Co., Ltd. The IPSC-CTL trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical preparations for treating tumours; Pharmaceutical preparations for cancer treatment; Pharmaceutical preparations for the treatment of autoimmune diseases; Immunoassay reagent for medical purposes; pharmaceutical preparations for cell function activation; pharmaceutical preparations for cell inhibition; Stem cells for medical purposes; Medical living cells; Medical cells; Medical nutritional preparations, namely, nutritional supplements
Blood collection service; Human tissue bank services; Medical screening; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Stem Cell Bank Services; Stem Cell Therapy Services; Medical treatment using cultured cells; Cultured cell bank services for medical transplantation; Medical services for removing, treating and processing stem cells; Medical services
Apparatus for the regeneration of stem cells for medical purposes; Blood transfusion apparatus; Cancer testing apparatus for medical purposes; Cancer diagnostic apparatus for medical purposes; Medical apparatus for analyzing tumours; Medical apparatus for analyzing cancer; Medical genetic testing apparatus; Medical apparatus and instruments for treating tumours; Medical apparatus and instruments for cancer treatment; Physiotherapy apparatus for treating tumours; Physiotherapy apparatus for cancer treatment; Medical radiation equipment, namely, Radiation therapy devices; Respirator for artificial respiration
General Information
Serial Number | 98393461 |
Word Mark | IPSC-CTL |
Filing Date | Tuesday, February 6, 2024 |
Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
Status Date | Tuesday, December 3, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Pharmaceutical preparations for treating tumours; Pharmaceutical preparations for cancer treatment; Pharmaceutical preparations for the treatment of autoimmune diseases; Immunoassay reagent for medical purposes; pharmaceutical preparations for cell function activation; pharmaceutical preparations for cell inhibition; Stem cells for medical purposes; Medical living cells; Medical cells; Medical nutritional preparations, namely, nutritional supplements |
Pseudo Mark | IPSCCTL |
Goods and Services | Blood collection service; Human tissue bank services; Medical screening; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Stem Cell Bank Services; Stem Cell Therapy Services; Medical treatment using cultured cells; Cultured cell bank services for medical transplantation; Medical services for removing, treating and processing stem cells; Medical services |
Goods and Services | Apparatus for the regeneration of stem cells for medical purposes; Blood transfusion apparatus; Cancer testing apparatus for medical purposes; Cancer diagnostic apparatus for medical purposes; Medical apparatus for analyzing tumours; Medical apparatus for analyzing cancer; Medical genetic testing apparatus; Medical apparatus and instruments for treating tumours; Medical apparatus and instruments for cancer treatment; Physiotherapy apparatus for treating tumours; Physiotherapy apparatus for cancer treatment; Medical radiation equipment, namely, Radiation therapy devices; Respirator for artificial respiration |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, February 6, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
US Class Codes | 026, 039, 044 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, February 6, 2024 |
Primary Code | 010 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, February 6, 2024 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Shanghai Xinghua Bio Pharmaceutical Science & Technology Co., Ltd |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Shanghai 201400 CN |
Trademark Events
Event Date | Event Description |
Tuesday, February 6, 2024 | NEW APPLICATION ENTERED |
Tuesday, June 4, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, August 29, 2024 | ASSIGNED TO EXAMINER |
Friday, August 30, 2024 | NON-FINAL ACTION E-MAILED |
Friday, August 30, 2024 | NON-FINAL ACTION WRITTEN |
Friday, August 30, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, December 2, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, December 2, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, December 3, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |